Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA “Rapid-Action” Team, Pre-Emption Included In GOP Bioterror Bill

Executive Summary

The Senate leadership's biodefense bill for 2005 would direct FDA to create a special compliance unit to help prevent shortages of vaccines

You may also be interested in...



Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents

Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)

Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents

Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)

Unused Flu Vaccine Would Be Purchased By HHS Under Draft “BioShield II”

The Centers for Disease Control & Prevention would purchase a percentage of unused influenza vaccine doses at the end of each flu season under a draft version of the "BioShield II" bill

Related Content

Topics

UsernamePublicRestriction

Register

PS045304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel